Skip to main content
InflaRx N.V. (IFRX)
NASDAQ: IFRX · Real-Time Price · USD
0.945
-0.026 (-2.63%)
At close: Mar 9, 2026, 4:00 PM EDT
0.951
+0.007 (0.71%)
After-hours: Mar 9, 2026, 4:10 PM EDT

InflaRx Revenue

InflaRx had revenue of 23.83K EUR in the quarter ending September 30, 2025, a decrease of -80.75%. This brings the company's revenue in the last twelve months to 62.84K, down -62.71% year-over-year. In the year 2024, InflaRx had annual revenue of 165.79K with 162.79% growth.

Revenue (ttm)
62.84K EUR
Revenue Growth
-62.71%
P/S Ratio
864.56
Revenue / Employee
849 EUR
Employees
74
Market Cap
63.99M USD

Revenue Chart

* This company reports financials in EUR.

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024165.79K102.70K162.79%
Dec 31, 202363.09K--
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020---
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Alterity Therapeutics 4.43M
ImageneBio 800.00K
Spruce Biosciences 697.00K
Mereo BioPharma Group 500.00K
Entera Bio 124.00K
Impact BioMedical 25.00K
eXoZymes -700.00
Revenue Rankings

IFRX News

More News